Keragon
177 Huntington Avenue, Suite 1703, Boston, Massachusetts, Not provided, United States
Overview
Keragon offers an AI-powered, HIPAA-compliant automation platform that enables healthcare professionals to integrate over 300 popular software tools—EHRs, scheduling, referral systems, and AI scribes—without engineering. The product is no-code and focuses on real-time data exchange to reduce administrative burdens and safeguard patient data. Six months after product launch the company has surpassed 100 paying customers, is growing at a 30% month-over-month rate, and has executed more than 2 million workflow automations. Customers report time savings and revenue uplift from streamlined workflows. Keragon plans to double down on AI-powered automation by adding an agentic AI layer to guide and personalize automations for individual providers and organizations. Integrations at scale remain the company’s stated top priority as it expands its compliant ecosystem. Keragon provides a no-code automation platform designed specifically for healthcare, enabling instant integration with EHRs, healthcare CRMs, AI medical scribes, appointment scheduling, and billing systems. The platform includes built-in personalized AI assistants, over 100 pre-built healthcare integrations, multiple data-transformation helpers, and advanced error-debugging capabilities. Typical use cases include two-way EHR‑to‑marketing synchronization, real-time appointment triage and stakeholder notifications, and facilitating patient data interoperability across disparate systems. Keragon is SOC 2 Type 2 and HIPAA certified by external auditors and is used by practices, clinics, fast-growing digital health startups, hospitals and NASDAQ‑listed companies across all 50 states. The company says its tools aim to reduce operational costs, improve clinical efficiency, lower physician burnout, and accelerate healthcare’s digital transformation.
- Total raised
- $11M
- Funding rounds
- 2
- Latest round
- Seed
- Latest activity
- Feb 2025
Industries
- Health Care
Recent funding
Seed
Feb 2025
$8M
Seed
Jun 2024
$3M
Team
No current team members are available.